Ovarian Cancer Drugs Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 20172025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Ovarian Cancer Drugs Market – Overview Ovarian cancer is one of the most dreadful cancers among all different cancers in females. Cancer which is grown in an ovary, results in abnormal cells growth that have the tendency to invade or adversely affect the other parts of the body. Only a few vague symptoms show up in the initial stages. Further symptoms manifest as the cancer grows. These symptoms include inflating, pelvic ache, abdominal puffiness, and loss of appetite. As this is an ovarian cancer, the cancer can spread to adjoining areas such as abdomen layers, lining of the bowel and bladder, lymph nodes, and liver. The disease is relatively rare, though risk is higher among women who have ovulated more over their lifetime, which can also include females who have never borne a child and those who began ovulating at a very young age. Around 10% of ovarian cancer cases are related to inherited genetic risk. Women with mutations in the breast cancer genes have a 50% chance of developing the disease. The most common ovarian cancer that accounts for 95% of cases, is ovarian carcinoma. An alarming rise in number of ovarian cancer cases reported in the recent past, inadvertently creates a highly conducive environment for growth of the ovarian cancer drugs market. According to estimates released by the American Cancer Society, in 2016, around 22,280 new cases of ovarian cancer were diagnosed, leading to 14,240 deaths in the U.S. Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Ovarian Cancer Drugs Market Taxonomy: The global ovarian cancer drugs market is segmented on the basis of chemotherapy drugs, end user, and geography. On the basis of chemotherapy drugs, the ovarian cancer drugs are divided into Carbloplastin, Cisplatin, Docetaxel, Paclitaxel and other medication includes Cyclophosphamide, Doxorubicin, Gemcitabine, Oxaliplatin and Topotecan. On the basis of end user, the market is classified into hospitals, ambulatory surgical centers, clinics, and others. Prevalence of ovarian cancer is usually low among women under 40 years of age. According to American Cancer Society, most of the ovarian cancer case are reported among women aged 60 years and above. According to Cancer Research UK, in 2014, 7,378 new cases of ovarian cancer were reported in the U.K., of which around 53% of cases diagnosed were among females aged 65 years and above.
Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/164 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Ovarian Cancer Drugs Market: Key Players ●
Bristol Myers Squibb Company.
●
Eli Lilly and Company.
●
GlaxoSmithKline plc.
●
Janssen Pharmaceuticals, Inc.
●
Novogen, Inc.
●
Genentech Inc.
●
Aetera Zenteris Inc.
●
Boehringer Ingelheim GmbH.
●
F. Hoffman-La Roche Ltd.
View this report @ https://www.coherentmarketinsights.com/ongoing-insight/ovarian-cancer-drugs-market-164 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS SECTOR COVERAGE Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY STUDIES
GLOBAL REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY ANALYSIS
CONSULT PROJECTS
SURVEY RESEARC H
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 Š Coherent market Insights. All Rights Reserved